Table 2.
Detected lesions by site and modality.
| Lesion site | Overall* N = 38 (24) | mpMRI N = 35 (19) | PET N = 25(16) | PET/MRI N = 33(24) |
|---|---|---|---|---|
| Prostate/-bed gland bed vesicle vesicle remnants |
17(9) 6(3) 5(5) 1(0) 5(1) |
16(8) 5(3) 5(5) 1(0) 5(0) |
9(4) 5(2) 3(1) 0(0) 1(1) |
14(9) 5(3) 5(5) 0(0) 4(1) |
| Intrapelvic nodes | 27(21) | 26(16) | 17(15) | 26(21) |
| Extrapelvic nodes | 8(4) | 4(2) | 7(3) | 7(4) |
| Bone | 2(1) | 1(0) | 1(1) | 1(1) |
| Total lesions | 54(35) | 47 (26) | 34(23) | 48(35) |
Number of lesions scored as equivocal or positive (score 2 or 3) is presented, with number lesions classified as positive (score 3) in brackets. *Lesions scored as positive/equivocal by either mpMRI, PET, or PET/MRI.